WATACHEM Wata Chemicals Limited
Pharmaceuticals & Chemicals
Tk 127.3 as of 2026-11-12 14:08:49
Data completeness 100%
Score breakdown
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Consistency Paid a dividend every year (5/5)
- Ownership Institutions (36.27%) hold more than the public (27.32%)
Concerns
- Consistency EPS rose in only 1 of 4 years (erratic or cyclical)
- Profitability Average ROE only 3.46% (below 10%: capital not working hard)
- Profitability Net profit shrinking 40.98% a year
- Valuation P/E 61.2 is high (above 20)
- Valuation Price is 136% above the Graham fair value (Tk 53.9)
Notes
- Solvency Debt/equity 0.54x (well managed)
Risk flags
- Small cap (< Tk 200 cr): most exposed to manipulation and volatility
- Thin trading (last day ~Tk 0.13 cr)
Valuation
52-week range
21.1% above the low, 19.4% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
Dividends and safety
Size, liquidity and ownership
Shareholding
- Sponsor/director 36.4%
- Institution 36.3%
- Public 27.3%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2021 | 6.14 | 60.22 | 9 | 30 | 0 |
| 2022 | 4.05 | 61.18 | 6 | 20 | 0 |
| 2023 | 3.03 | 62.51 | 4 | 15 | 0 |
| 2024 | 0.67 | 61.6 | 1 | 12 | 0 |
| 2025 | 0.74 | 61.09 | 1 | 10 | 0 |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 26.6%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.